<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01759706</url>
  </required_header>
  <id_info>
    <org_study_id>ERAS_PANCREAS 01</org_study_id>
    <nct_id>NCT01759706</nct_id>
  </id_info>
  <brief_title>Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy</brief_title>
  <official_title>Safety and Feasibility Study of an Enhanced Recovery After Surgery Protocol in Patients Undergoing Elective Pancreaticoduodenectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università Vita-Salute San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ospedale San Raffaele</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Università Vita-Salute San Raffaele</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the adherence to an enhanced recovery after surgery
      (ERAS) pathway and the impact of the ERAS protocol on postoperative short-term outcome in
      patients undergoing pancreaticoduodenectomy (PD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A specific enhanced recovery after surgery (ERAS) protocol has been applied since October
      2010 in consecutive patients undergoing pancreaticoduodenectomy (PD) in a high volume
      Institution. Patient compliance for each item has been assessed. Each ERAS patient was
      matched with a patient who received standard perioperative care. Match criteria were age,
      gender, malignant / benign disease, and PD prognostic score.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to the pathway</measure>
    <time_frame>Participants will be followed from two weeks before surgery, for the duration of hospital stay, and for 30 days after discharge, an expected average of 8 weeks.</time_frame>
    <description>Adherence to single items of the pathway.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative outcome</measure>
    <time_frame>The outcomes will be assessed for the duration of hospital stay and for 30 days after discharge</time_frame>
    <description>Comparison of postoperative morbidity and mortality, length of hospital stay, readmission.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Pancreatic Neoplasms</condition>
  <arm_group>
    <arm_group_label>Enhanced Recovery After Surgery (ERAS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients treated with enhanced recovery after surgery protocol: preadmission counselling, preoperative immunonutrition, no preoperative bowel preparation, epidural analgesia with naropin + sufentanil, no pre-anesthetic medication, intraoperative iv fluid restriction, PONV prophylaxis with ondansetron + dexamethasone, hypothermia prophylaxis, removal of nasogastric tube (NGT) at the end of surgery, postoperative mobilization program, solid food diet from POD 2, early stop of iv infusions and removal of urinary catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard perioperative care (Control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with standard care perioperative protocol: epidural analgesia with naropin + sufentanil, pre-anesthetic medication with diazepam, Preoperative bowel preparation with sodium phosphate, removal of nasogastric tube on POD 1, solid food diet from POD 4</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced recovery after surgery protocol</intervention_name>
    <description>ERAS items implemented were: preadmission counselling, preoperative immunonutrition, no preoperative bowel preparation, epidural analgesia, no pre-anesthetic medication, intraoperative iv fluid restriction, PONV and hypothermia prophylaxis, removal of nasogastric tube (NGT) at the end of surgery, mobilization protocol, solid food diet from POD 2, early stop of iv infusions and removal of urinary catheter.</description>
    <arm_group_label>Enhanced Recovery After Surgery (ERAS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard perioperative care</intervention_name>
    <description>Epidural analgesia, pre-anesthetic medication with diazepam, bowel preparation with oral assumption of sodium phosphate, removal of nasogastric tube on POD 1, solid food diet from POD 4</description>
    <arm_group_label>Standard perioperative care (Control)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PONV prophylaxis with Ondansetron + Dexamethasone</intervention_name>
    <description>Postoperative nausea and vomiting prophylaxis with Ondansetron + Dexamethasone.</description>
    <arm_group_label>Enhanced Recovery After Surgery (ERAS)</arm_group_label>
    <other_name>Zofran + Decadron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Postoperative mobilization program</intervention_name>
    <description>Patient mobilization for 2 hours on first postoperative day Patient mobilization for 4 hours on first postoperative day + assisted deambulation in the room Patient mobilization for 6 hours on first postoperative day + assisted deambulation in the ward</description>
    <arm_group_label>Enhanced Recovery After Surgery (ERAS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural analgesia with naropin + sufentanil</intervention_name>
    <description>Midthoracic epidural analgesia with naropin 0.2 % plus sufentanil 0,5 mcg/mL</description>
    <arm_group_label>Enhanced Recovery After Surgery (ERAS)</arm_group_label>
    <arm_group_label>Standard perioperative care (Control)</arm_group_label>
    <other_name>Disufen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pre-anesthetic medication with diazepam</intervention_name>
    <description>Premedication before general anesthesia</description>
    <arm_group_label>Standard perioperative care (Control)</arm_group_label>
    <other_name>Valium</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Preadmission counselling</intervention_name>
    <description>Patient multidisciplinary preoperative counselling, including anesthesiologist, surgeon and nurse.</description>
    <arm_group_label>Enhanced Recovery After Surgery (ERAS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Preoperative bowel preparation with sodium phosphate</intervention_name>
    <description>Preoperative bowel preparation with oral assumption of sodium phosphate</description>
    <arm_group_label>Standard perioperative care (Control)</arm_group_label>
    <other_name>Phospho-Lax</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients undergoing elective pancreaticoduodenectomy

        Exclusion Criteria:

          -  Intraoperative detection of metastatic disease (non-operability)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Braga, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università Vita-Salute San Raffaele</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <state>MI</state>
        <zip>20129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Balzano G, Zerbi A, Braga M, Rocchetti S, Beneduce AA, Di Carlo V. Fast-track recovery programme after pancreatico- duodenectomy reduces delayed gastric emptying. Br J Surg. 2008 Nov;95(11):1387-93. doi: 10.1002/bjs.6324.</citation>
    <PMID>18844251</PMID>
  </reference>
  <reference>
    <citation>Lassen K, Coolsen MM, Slim K, Carli F, de Aguilar-Nascimento JE, Schäfer M, Parks RW, Fearon KC, Lobo DN, Demartines N, Braga M, Ljungqvist O, Dejong CH; Enhanced Recovery After Surgery (ERAS) Society, for Perioperative Care; European Society for Clinical Nutrition and Metabolism (ESPEN); International Association for Surgical Metabolism and Nutrition (IASMEN). Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. World J Surg. 2013 Feb;37(2):240-58. doi: 10.1007/s00268-012-1771-1.</citation>
    <PMID>22956014</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2012</study_first_submitted>
  <study_first_submitted_qc>January 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 3, 2013</study_first_posted>
  <last_update_submitted>December 3, 2014</last_update_submitted>
  <last_update_submitted_qc>December 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università Vita-Salute San Raffaele</investigator_affiliation>
    <investigator_full_name>Marco Braga</investigator_full_name>
    <investigator_title>Professor in Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Diazepam</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

